Poly(2-ethyl-2-oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility

Macromolecular Bioscience

Volumn 12, Issue 7, 2012, Pages 986-998

  Bauer, Marius ^a   Lautenschlaeger, Christian ^a   Kempe, Kristian ^a   Tauhardt, Lutz ^a   Schubert, Ulrich S ^a   Fischer, Dagmar ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Biocompatibility; Hydrophilic polymers; Poly(2 oxazoline)s; Poly(ethylene glycol)s; Stealth effect

Indexed keywords

CLINICAL TRIAL; CYTOTOXIC EFFECTS; HEMOCOMPATIBILITY; HIGH CONCENTRATION; HIGH STABILITY; HYDROPHILIC POLYMERS; IN-VITRO; LONG-TERM INCUBATION; LOW VISCOSITY; MICROWAVE-ASSISTED; MODERATE CONCENTRATION; PHYSICOCHEMICAL CHARACTERISTICS; POLY(2-ETHYL-2-OXAZOLINE); POLY(2-OXAZOLINE)S; STEALTH EFFECT; THERAPEUTIC DOSE;

BIOCOMPATIBILITY; CYTOTOXICITY; DRUG DELIVERY; LIVING POLYMERIZATION; NITROGEN COMPOUNDS; POLYETHYLENE GLYCOLS;

POLYMERS;

LACTATE DEHYDROGENASE; MACROGOL; POLY(2 ETHYL 2 OXAZOLINE); POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; FIBROBLAST; HEMOLYSIS; IN VITRO STUDY; MOLECULAR STABILITY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; VISCOSITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; DRUG CARRIERS; DRUG STABILITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FIBROBLASTS; HEMOLYSIS; L-LACTATE DEHYDROGENASE; MICE; MICROWAVES; POLYAMINES; POLYETHYLENE GLYCOLS; POLYMERIZATION; VISCOSITY;

EID: 84863736611     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201200017     Document Type: Article

References (41)

1. S. Grund, M. Bauer, D. Fischer, Adv. Eng. Mater. 2011, 13, B61.
2. K. Knop, R. Hoogenboom, D. Fischer, U. S. Schubert, Angew. Chem., Int. Ed. 2010, 49, 6288.
3. I. Hamad, A. C. Hunter, J. Szebeni, S. M. Moghimi, Mol. Immunol. 2008, 46, 225.
4. T. Tagami, K. Nakamura, T. Shimizu, N. Yamazaki, T. Ishida, H. Kiwada, J. Controlled Release 2010, 142, 160.
5. H. Koide, T. Asai, K. Hatanaka, S. Akai, T. Ishii, E. Kenjo, T. Ishida, H. Kiwada, H. Tsukada, N. Oku, Int. J. Pharm. 2010, 392, 218.
6. G. Pasut, F. M. Veronese, Prog. Polym. Sci. 2007, 32, 933.
7. M. C. Woodle, C. M. Engbers, S. Zalipsky, Bioconjugate Chem. 1994, 5, 493.
8. F. Wiesbrock, R. Hoogenboom, C. H. Abeln, U. S. Schubert, Macromol. Rapid Commun. 2004, 25, 1895.
9. A. Mero, G. Pasut, L. D. Via, M. W. M. Fijten, U. S. Schubert, R. Hoogenboom, F. M. Veronese, J. Controlled Release 2008, 125, 87.
10. T. X. Viegas, M. D. Bentley, J. M. Harris, Z. Fang, K. Yoon, B. Dizman, R. Weimer, A. Mero, G. Pasut, F. M. Veronese, Bioconjug. Chem. 2011, 22, 976.
11. S. Cheon Lee, C. Kim, I. Chan Kwon, H. Chung, S. Young Jeong, J. Controlled Release 2003, 89, 437.
12. J. Kronek, Z. Kroneková, J. Lustoň, E. Paulovičová, L. Paulovičová, B. Mendrek, J. Mater. Sci.: Mater. Med. 2011, 22, 1725.
13. R. Luxenhofer, G. Sahay, A. Schulz, D. Alakhova, T. K. Bronich, R. Jordan, A. V. Kabanov, J. Controlled Release 2011, 153, 73.
14. T. Mosmann, J. Immunol. Methods 1983, 65, 55.
15. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, T. Kissel, Biomaterials 2003, 24, 1121.
16. " Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity", 2nd edition, International Organization for Standardization/ANSI;ISO ISO 10993-5, Geneva, Switzerland: 2009.
17. S. Choksakulnimitr, S. Masuda, H. Tokuda, Y. Takakura, M. Hashida, J. Controlled Release 1995, 34, 233.
18. M. J. Parnham, H. Wetzig, Chem. Phys. Lipids 1993, 64, 263.
19. ASTM F756, 2000 (2008), " Standard Practice for Assessment of Hemolytic Properties of Materials", in Annual Book of ASTM Standards, Vol. 13. 01, ASTM, Philadelphia 2008.
20. M. Ogris, S. Brunner, S. Schuller, R. Kircheis, E. Wagner, Gene Ther. 1999, 6, 595.
21. H. Petersen, P. M. Fechner, A. L. Martin, K. Kunath, S. Stolnik, C. J. Roberts, D. Fischer, M. C. Davies, T. Kissel, Bioconjug. Chem. 2002, 13, 845.
22. A. V. Cardoso, M. H. Pereira, G. d. A. Marcondes, A. R. Ferreira, P. R. d. Araújo, Mater. Res. 2007, 10, 31.
23. S. Kobayashi, E. Masuda, S. Shoda, Y. Shimano, Macromolecules 1989, 22, 2878.
24. ASTM F0813, 1996 (2007), " Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices", in Annual Book of ASTM Standards, Vol. 13.01, ASTM, Philadelphia 2008.
25. D. A. Herold, K. Keil, D. E. Bruns, Biochem. Pharmacol. 1989, 38, 73.
26. L. Scott, J. Yao, A. Benson, A. Thomas, S. Falk, R. Mena, J. Picus, J. Wright, M. Mulcahy, J. Ajani, T. Evans, Cancer Chemother. Pharmacol. 2009, 63, 363.
27. E. H. Luh, S. R. Shackford, M. A. Shatos, J. A. Pietropaoli, J. Surg. Res. 1996, 60, 122.
28. F. Schroeder, J. Membr. Biol. 1982, 68, 141.
29. R. F. A. Zwall, B. Roelofsen, C. Michael Colley, Biochim. Biophys. Acta, Rev. Biomembr. 1973, 300, 159.
30. D. Sgouras, R. Duncan, J. Mater. Sci.: Mater. Med. 1990, 1, 61.
31. X. Y. Liu, J.-M. Nothias, A. Scavone, M. Garfinkel, J. M. Millis, ASAIO J. 2010, 56, 241.
32. H. F. Smyth, C. P. Carpenter, C. S. Weil, J. Am. Pharm. Assoc. 1950, 39, 349.
33. J. D. Michaels, E. T. Papoutsakis, J. Biotechnol. 1991, 19, 241.
34. R. Barbucci, S. Lamponi, A. M. Aloisi, J. Biomed. Mater. Res. 1999, 46, 186.
35. J. F. Krzyzaniak, D. M. Raymond, S. H. Yalkowsky, Int. J. Pharm. 1997, 152, 193.
36. B. L. Smith, D. E. Cadwallader, J. Pharm. Sci. 1967, 56, 351.
37. J. Farrant, A. E. Woolgar, Cryobiology 1970, 7, 56.
38. N. M. Geller, V. A. Kropachev, V. A. Levtov, I. V. Potapova, Polym. Med. 1981, 11, 83.
39. V. A. Levtov, V. N. Shuvaeva, N. Shustova, A. T. Matchanov, T. V. Kim, Fiziol Zh SSSR Im I M Sechenova 1991, 77, 72.
40. I. B. Mosbah, R. Franco-Gou, H. B. Abdennebi, R. Hernandez, G. Escolar, D. Saidane, J. Rosello-Catafau, C. Peralta, Transplant. Proc. 2006, 38, 1229.
41. J. K. Armstrong, R. B. Wenby, H. J. Meiselman, T. C. Fisher, Biophys. J. 2004, 87, 4259.